bluebird bio, Inc.
BLUEDelisted Jun 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001293971
bluebird bio, Inc. was delisted on Jun 2, 2025; its insiders filed their last Form 4 on Jun 3, 2025; 85 institutions reported holding it in 13F filings for Q1 2025, worth $17.1M in total; no superinvestor held it.
Q4 2024 vs. Q3 2024
How the institutions holding bluebird bio, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 140 | 2 | 83 | −55 |
| SharesConverted for a 1-for-20 split | 3.14M | 1.45K | 2.85M | −280.1K (−8.9%) |
| Value | $32.9M | $15.1K | $23.8M | −$9.03M (−27.5%) |
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held bluebird bio, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| PFM Health Sciences, LP | 75,758 | $631.8K | 0.05% |
| Regeneron Pharmaceuticals, Inc. | 21,000 | $175.1K | 0.02% |
| Police & Firemen's Retirement System of New Jersey | 2,731 | $22.8K | 0.00% |
| Federation des caisses Desjardins du Quebec | 1,070 | $8.92K | 0.00% |
| Leonteq Securities AG | 999 | $8.33K | 0.00% |
| SBI Securities Co., Ltd. | 205 | $1.71K | 0.00% |
| Geneos Wealth Management Inc. | 176 | $1.47K | 0.00% |
| Nisa Investment Advisors, LLC | 159 | $1.33K | 0.00% |
| Raiffeisen Bank International AG | 112 | $972 | 0.00% |
| Vermillion Wealth Management, Inc. | 114 | $951 | 0.00% |
| Rothschild Investment LLC | 45 | $375 | 0.00% |
| Bell Investment Advisors, Inc | 33 | $276 | 0.00% |
| GAMMA Investing LLC | 19 | $158 | 0.00% |
| MAI Capital Management | 15 | $126 | 0.00% |
| Danske Bank A/S | 10 | $83 | 0.00% |
| Jones Financial Companies LLLP | 10 | $83 | 0.00% |
| JFS Wealth Advisors, LLC | 5 | $42 | 0.00% |
| Hager Investment Management Services, LLC | 5 | $42 | 0.00% |
Sold out (73)
Institutions that held bluebird bio, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
Not filed for Q4 2024 yet (2)
Institutions that held bluebird bio, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Raymond James Financial Services Advisors, Inc. | 28,710 | $14.9K |
| Halpern Financial, Inc. | 300 | $146 |